At the time of writing, Agilon Health Inc [AGL] stock is trading at $3.50, up 8.70%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AGL shares have gain 11.11% over the last week, with a monthly amount drifted -0.85%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on October 02, 2024, when BofA Securities downgraded its rating to a Underperform but kept the price target unchanged to $3 for it. Previously, Robert W. Baird started tracking the stock with Neutral rating on May 30, 2024, and set its price target to $6. On April 22, 2024, Citigroup initiated with a Neutral rating and assigned a price target of $6 on the stock. Barclays started tracking the stock assigning a Underweight rating and suggested a price target of $5 on March 06, 2024. TD Cowen downgraded its rating to a Market Perform and reduced its price target to $6.50 on February 26, 2024. Jefferies downgraded its rating to Hold for this stock on February 26, 2024, and downed its price target to $6.50. In a note dated January 08, 2024, Wolfe Research downgraded an Peer Perform rating on this stock.
For the past year, the stock price of Agilon Health Inc fluctuated between $2.99 and $20.37. Currently, Wall Street analysts expect the stock to reach $4.88 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $3.50 at the most recent close of the market. An investor can expect a potential return of 39.43% based on the average AGL price forecast.
Analyzing the AGL fundamentals
According to Agilon Health Inc [NYSE:AGL], the company’s sales were 5.36B for trailing twelve months, which represents an 29.04% jump. Gross Profit Margin for this corporation currently stands at 0.0% with Operating Profit Margin at -0.05%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.33 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.27 points at the first support level, and at 3.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.63, and for the 2nd resistance point, it is at 3.75.
Ratios To Look Out For
It is important to note that Agilon Health Inc [NYSE:AGL] has a current ratio of 1.36. As well, the Quick Ratio is 1.36, while the Cash Ratio is 0.08. Considering the valuation of this stock, the price to sales ratio is 0.27, the price to book ratio is 2.13.
Transactions by insiders
Recent insider trading involved Sell Steven, CEO & President, that happened on Sep 12 ’24 when 20000.0 shares were purchased. Director, Schwaneke Jeffrey A. completed a deal on Nov 29 ’23 to buy 22300.0 shares.
